CoreCap Advisors’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Sell
4,801
-24,431
-84% -$1.53M 0.01% 692
2026
Q1
$1.8M Sell
29,232
-28,580
-49% -$1.85M 0.06% 249
2025
Q4
$3.76M Buy
57,812
+53,656
+1,291% +$3.39M 0.13% 157
2025
Q3
$244K Hold
4,156
0.01% 740
2025
Q2
$235K Hold
4,156
0.01% 695
2025
Q1
$253K Buy
4,156
+85
+2% +$5.19K 0.01% 622
2024
Q4
$237K Sell
4,071
-257
-6% -$15.9K 0.01% 658
2024
Q3
$281K Buy
+4,328
New +$277K 0.01% 593
2024
Q2
Sell
-4,640
Closed -$287K 2124
2024
Q1
$287K Buy
+4,640
New +$279K 0.02% 539
2023
Q4
Sell
-12,865
Closed -$695K 622
2023
Q3
$695K Buy
+12,865
New +$719K 0.05% 275
2022
Q4
$2.04M Buy
+35,865
New +$1.98M 0.15% 123
2022
Q3
Sell
-8,135
Closed -$438K 1316
2022
Q2
$438K Buy
+8,135
New +$447K 0.03% 344
2022
Q1
Sell
-1,610
Closed -$97K 1316
2021
Q4
$97K Buy
+1,610
New +$92K 0.01% 760

Other funds holding IYH

CoreCap Advisors's IYH Position: Q2 2026 in Review

CoreCap Advisors reduced its iShares US Healthcare ETF (IYH) stake by 84% in Q2 2026, selling an estimated $1.53M and leaving 4,801 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #692.

CoreCap Advisors first reported a position in IYH in Q4 2021 and has held it in 13 quarters since. The position peaked at $3.76M in Q4 2025. 529 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • CoreCap Advisors held 4,801 shares of iShares US Healthcare ETF worth $322K as of Q2 2026.
  • CoreCap Advisors sold 24,431 iShares US Healthcare ETF shares in Q2 2026, an estimated $1.53M.
  • iShares US Healthcare ETF made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #692 holding.
  • CoreCap Advisors first reported a position in iShares US Healthcare ETF in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's iShares US Healthcare ETF position peaked at $3.76M in Q4 2025.
  • 529 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.